|
1
|
Jackman DM and Johnson BE: Small-cell lung
cancer. Lancet. 366:1385–1396. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar
|
|
3
|
Govindan R, Page N, Morgensztern D, et al:
Changing epidemiology of small-cell lung cancer in the United
States over the last 30 years: analysis of the surveillance,
epidemiologic, and end results database. J Clin Oncol.
24:4539–4544. 2006.PubMed/NCBI
|
|
4
|
Lally BE, Urbanic JJ, Blackstock AW,
Miller AA and Perry MC: Small cell lung cancer: have we made any
progress over the last 25 years? Oncologist. 12:1096–1104.
2007.PubMed/NCBI
|
|
5
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shimono Y, Zabala M, Cho RW, et al:
Downregulation of miRNA-200c links breast cancer stem cells with
normal stem cells. Cell. 138:592–603. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar
|
|
8
|
Yu F, Yao H, Zhu P, et al: let-7 regulates
self renewal and tumorigenicity of breast cancer cells. Cell.
131:1109–1123. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ma S, Tang KH, Chan YP, et al: miR-130b
promotes CD133(+) liver tumor-initiating cell growth and
self-renewal via tumor protein 53-induced nuclear protein 1. Cell
Stem Cell. 7:694–707. 2010.PubMed/NCBI
|
|
10
|
Liu C, Kelnar K, Liu B, et al: The
microRNA miR-34a inhibits prostate cancer stem cells and metastasis
by directly repressing CD44. Nat Med. 17:211–215. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hua S, Xiaotao X, Renhua G, et al: Reduced
miR-31 and let-7 maintain the balance between differentiation and
quiescence in lung cancer stem-like side population cells. Biomed
Pharmacother. 66:89–97. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ji Q, Hao X, Zhang M, et al: MicroRNA
miR-34 inhibits human pancreatic cancer tumor-initiating cells.
PLoS One. 4:e68162009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gal H, Pandi G, Kanner AA, et al: MIR-451
and Imatinib mesylate inhibit tumor growth of glioblastoma stem
cells. Biochem Biophys Res Commun. 376:86–90. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qiu X, Wang Z, Li Y, Miao Y, Ren Y and
Luan Y: Characterization of sphere-forming cells with stem-like
properties from the small cell lung cancer cell line H446. Cancer
Lett. 323:161–170. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bolstad BM, Irizarry RA, Astrand M and
Speed TP: A comparison of normalization methods for high density
oligonucleotide array data based on variance and bias.
Bioinformatics. 19:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen C, Ridzon DA, Broomer AJ, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Melton C, Judson RL and Blelloch R:
Opposing microRNA families regulate self-renewal in mouse embryonic
stem cells. Nature. 463:621–626. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu C and Tang DG: MicroRNA regulation of
cancer stem cells. Cancer Res. 71:5950–5954. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
DeSano JT and Xu L: MicroRNA regulation of
cancer stem cells and therapeutic implications. AAPS J. 11:682–692.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zimmerman AL and Wu S: MicroRNAs, cancer
and cancer stem cells. Cancer Lett. 300:10–19. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kohu K, Feng J, Iwama A and Satake M:
MicroRNA-27 enhances differentiation of myeloblasts into
granulocytes by post-transcriptionally downregulating Runx1. Br J
Haematol. 145:412–423. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Buckingham M, Crist CG, Montarras D, et
al: Muscle stem cell behavior is modified by microRNA-27 regulation
of Pax3 expression. Proc Natl Acad Sci USA. 106:13383–13387. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takamizawa J, Konishi H, Yanagisawa K, et
al: Reduced expression of the let-7 microRNAs in human lung cancers
in association with shortened postoperative survival. Cancer Res.
64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang GL, Zhang XH, Guo GL, et al:
Clinical significance of miR-21 expression in breast cancer:
SYBR-Green I-based real-time RT-PCR study of invasive ductal
carcinoma. Oncol Rep. 21:673–679. 2009.PubMed/NCBI
|
|
25
|
Shao JY, Yan LX, Huang XF, et al: MicroRNA
miR-21 overexpression in human breast cancer is associated with
advanced clinical stage, lymph node metastasis and patient poor
prognosis. RNA. 14:2348–2360. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Asangani IA, Rasheed SA, Nikolova DA, et
al: MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor
suppressor Pdcd4 and stimulates invasion, intravasation and
metastasis in colorectal cancer. Oncogene. 27:2128–2136. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY and
Yan M: microRNA-21 promotes tumor proliferation and invasion in
gastric cancer by targeting PTEN. Oncol Rep. 27:1019–1026.
2012.PubMed/NCBI
|
|
28
|
Gao W, Shen H, Liu L, Xu J and Shu Y:
MiR-21 overexpression in human primary squamous cell lung carcinoma
is associated with poor patient prognosis. J Cancer Res Clin Oncol.
137:557–566. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu S, Wu H, Wu F, Nie D, Sheng S and Mo
YY: MicroRNA-21 targets tumor suppressor genes in invasion and
metastasis. Cell Res. 18:350–359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hiyoshi Y, Kamohara H, Karashima R, et al:
MicroRNA-21 regulates the proliferation and invasion in esophageal
squamous cell carcinoma. Clin Cancer Res. 15:1915–1922. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Horiuchi A, Iinuma H, Akahane T, Shimada R
and Watanabe T: Prognostic significance of PDCD4 expression and
association with microRNA-21 in each Dukes’ stage of colorectal
cancer patients. Oncol Rep. 27:1384–1392. 2012.PubMed/NCBI
|
|
32
|
Zhu Q, Wang Z, Hu Y, et al: miR-21
promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback
loop in human hepatocellular carcinoma. Oncol Rep. 27:1660–1668.
2012.PubMed/NCBI
|
|
33
|
Singh SK, Kagalwala MN, Parker-Thornburg
J, Adams H and Majumder S: REST maintains self-renewal and
pluripotency of embryonic stem cells. Nature. 453:223–227. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Houbaviy HB, Murray MF and Sharp PA:
Embryonic stem cell-specific MicroRNAs. Dev Cell. 5:351–358. 2003.
View Article : Google Scholar : PubMed/NCBI
|
